Shionogi
Helen Chang is an accomplished marketing professional with extensive experience in the pharmaceutical and healthcare industries. Currently serving as the Head of Rare Diseases Marketing at Shionogi Inc., Helen has previously held leadership roles such as VP of Marketing at Mesoblast Limited and Executive Director of Hospital Marketing and Global Brand Lead for Inomax and Therakos at Mallinckrodt Pharmaceuticals. Additionally, Helen has experience as a Senior Director in Rare Diseases and as a Senior Business Consultant at HCH Consulting, alongside serving as a Board Member for the National Sleep Foundation. Helen Chang holds a Bachelor of Science degree in Pharmacy from Rutgers University.
This person is not in any teams
Shionogi
10 followers
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.